Catheter-related Saccharomyces cerevisiae Fungemia Following Saccharomyces boulardii Probiotic Treatment: In a child in intensive care unit and review of the literature
0301 basic medicine
Medicine (General)
0303 health sciences
QH301-705.5
Case Report
Saccharomyces cerevisiae
3. Good health
Saccharomyces boulardii
03 medical and health sciences
Probiotic treatment
R5-920
Intensive care unit
Biology (General)
Fungemia
DOI:
10.1016/j.mmcr.2017.02.002
Publication Date:
2017-02-23T00:01:02Z
AUTHORS (7)
ABSTRACT
Although Saccharomyces boulardii is usually a non-pathogenic fungus, in rare occasions it can cause invasive infection in children. We present the case of an 8-year-old patient in pediatric surgical intensive care unit who developed S. cerevisiae fungemia following probiotic treatment containing S. boulardii. Caspofungin was not effective in this case and he was treated with amphotericin B. We want to emphasize that physicians should be careful about probiotic usage in critically ill patients.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (20)
CITATIONS (40)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....